Acquisition History / Swedencare AB / Summit Veterinary Pharmaceuticals Limited
Swedencare AB Acquires Summit Veterinary Pharmaceuticals Limited
Announced March 24, 2025 — $60.8M
What happened
Summit is an Oxford-area supplier of veterinary 'specials' medicines with £7.3M revenue and a 37% EBITDA margin. Nasdaq Stockholm-listed Swedencare bought 100%, with the founder staying on for two years; closing was expected on 1 April 2025.
- Acquirer
- Swedencare AB
- Target
- Summit Veterinary Pharmaceuticals Limited
- Announced
- March 24, 2025
- Price
- $60.8M
- Industry
- Veterinary specials pharmaceuticals
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Swedencare AB acquire Summit Veterinary Pharmaceuticals Limited?
Swedencare AB acquired Summit Veterinary Pharmaceuticals Limited on March 24, 2025. This was Swedencare AB's 1st publicly tracked acquisition out of 1 we have on record.
How much did Swedencare AB pay for Summit Veterinary Pharmaceuticals Limited?
Swedencare AB paid $60.8M for Summit Veterinary Pharmaceuticals Limited.
What does Summit Veterinary Pharmaceuticals Limited do?
Summit is an Oxford-area supplier of veterinary 'specials' medicines with £7.3M revenue and a 37% EBITDA margin. Nasdaq Stockholm-listed Swedencare bought 100%, with the founder staying on for two years; closing was expected on 1 April 2025.
What other Veterinary specials pharmaceuticals companies has Swedencare AB acquired?
Summit Veterinary Pharmaceuticals Limited is Swedencare AB's only publicly tracked acquisition in Veterinary specials pharmaceuticals so far.